Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Watson Takes Stake In Brazil's Moksha8

This article was originally published in The Pink Sheet Daily

Executive Summary

The Sao Paolo-based company will market about a dozen of Watson's generics in Mexico and Brazil, with potential for more.

You may also be interested in...

Emerging Views On Emerging Markets: Credit Suisse Healthcare Conference

PharmAsia News takes a closer look at presentations by Baxter, Forest, J&J, Novartis and Zimmer.

Watson Pharma Defends Ascent Buyout; Bigger Scale Will Offset Price Cuts In Australia

Emerging Markets Round Up From JP Morgan Healthcare Conference (Part 2 of 2)

[Editor's note: This is part two of a story carrying highlights on emerging markets from the annual JP Morgan Healthcare Conference in San Francisco last week.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts